{
    "title": "AstraZeneca shares drop as lung cancer trial update lags expectations",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12258317/AstraZeneca-shares-drop-lung-cancer-trial-update-lags-expectations.html",
    "date": "2023-07-03",
    "keywords": [
        "drug",
        "lung",
        "trial",
        "cancer",
        "treatment",
        "astrazeneca",
        "maggie",
        "fick",
        "burger",
        "survival",
        "chemotherapy",
        "class",
        "trop2",
        "breast",
        "note",
        "reporting",
        "ludwig",
        "july",
        "monday",
        "precision",
        "progression",
        "datopotamab",
        "deruxtecan",
        "sankyo",
        "cell",
        "consist",
        "drugmaker",
        "disease",
        "scarring",
        "tissue",
        "safety",
        "profile",
        "line",
        "conference",
        "level",
        "protein",
        "majority",
        "targeting",
        "adc",
        "bladder",
        "merck",
        "co",
        "partner",
        "kelunbiotech",
        "china",
        "development",
        "stage",
        "candidate",
        "collaboration",
        "deal",
        "contingent",
        "pact",
        "enhertu",
        "effect",
        "efficacy",
        "criterion",
        "analyst",
        "choice",
        "diagnosis",
        "datodxd",
        "number",
        "reaction",
        "today",
        "buying",
        "opportunity",
        "frankfurt",
        "mitra",
        "raitano",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}